InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (22 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
22
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Knowles Julius, Director. Officer active across 1 company, notably Keros Therapeutics, Inc.. Cumulatively, 23 reports have been published. Breakdown: 1 buy · 22 sells. Total volume traded: €5.4m. Activity tracked since 3 May 2021. The latest transaction was filed on 13 April 2020 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations23 total
1,191 shares@ US$20.980.4% of flowCommon StockSEC:0001209191-23-004279:0
Ideal exit: 8 Jan 2021 (T+270)
3,678 shares@ US$56.820.030% mcap7.2% of flowCommon StockSEC:0001209191-22-001990
3,678 shares@ US$56.820.030% mcap3.4% of flowCommon StockSEC:0001209191-22-001990:0
4,243 shares@ US$53.480.032% mcap7.8% of flowCommon StockSEC:0001209191-21-067877
4,243 shares@ US$53.480.032% mcap3.7% of flowCommon StockSEC:0001209191-21-067877:0
7,057 shares@ US$41.850.041% mcap4.8% of flowCommon StockSEC:0001209191-21-062812:0
7,057 shares@ US$41.850.041% mcap10.0% of flowCommon StockSEC:0001209191-21-062812
2,029 shares@ US$38.050.011% mcap2.6% of flowCommon StockSEC:0001209191-21-061256
2,029 shares@ US$38.050.011% mcap1.2% of flowCommon StockSEC:0001209191-21-061256:0
2,653 shares@ US$40.130.015% mcap1.7% of flowCommon StockSEC:0001209191-21-060784:0
2,653 shares@ US$40.130.015% mcap3.6% of flowCommon StockSEC:0001209191-21-060784
3,827 shares@ US$40.160.021% mcap2.5% of flowCommon StockSEC:0001209191-21-059749:0
3,827 shares@ US$40.160.021% mcap5.2% of flowCommon StockSEC:0001209191-21-059749
27,373 shares@ US$40.510.15% mcap17.7% of flowCommon StockSEC:0001209191-21-058061:0
27,373 shares@ US$40.5117.6% of flowCommon StockSEC:0001209191-21-058061
13,268 shares@ US$41.220.074% mcap8.6% of flowCommon StockSEC:0001209191-21-045620:0
13,268 shares@ US$41.228.6% of flowCommon StockSEC:0001209191-21-045620
2,988 shares@ US$47.230.019% mcap2.2% of flowCommon StockSEC:0001209191-21-038917:0
2,988 shares@ US$47.232.2% of flowCommon StockSEC:0001209191-21-038917
2,309 shares@ US$51.900.016% mcap1.8% of flowCommon StockSEC:0001209191-21-037974:0
2,309 shares@ US$51.901.8% of flowCommon StockSEC:0001209191-21-037974
5,383 sharesCommon StockSEC:0001209191-21-030410
5,383 shares@ US$56.040.040% mcap4.7% of flowCommon StockSEC:0001209191-21-030410:0
23 of 23 declarations
About Knowles Julius
Knowles Julius is a director at Keros Therapeutics, Inc.
